| Issue |
Section |
Title |
File |
| Vol 16, No 3 (2009) |
Articles |
Vildagliptin - a new dipeptidylpeptidase-4 inhibitor for the treatment of type 2 diabetes mellitus |
|
| Vol 16, No 3 (2009) |
Articles |
Prospects of the first human glucagon-like peptide 1 analog liraglutid use in the treatment of patients with type 2 diabetes mellitus |
|
| Vol 16, No 3 (2009) |
Articles |
Experience of incritinomimetic exenatide (Byetta) use in the treatment of patients with type 2 diabetes mellitus with obesity |
|
| Vol 16, No 3 (2009) |
Articles |
Possibilities of insulin glargine (Lantus ®) use for treatment of type 2 diabetes mellitus in the outpatient endocrinology services: an analysis of the register LAUREL |
|
| Vol 16, No 3 (2009) |
Articles |
Effect of alpha-lipoic acid (Tiogamma) on the quality of life of patients with diabetic peripheral polyneuropathy |
|
| Vol 16, No 17 (2009) |
Articles |
ROSIGLITAZON: BEZOPASNOST', EFFEKTIVNOST' I VLIYaNIE NA KARDIOVASKULYaRNYE ISKhODY U PATsIENTOV S SAKhARNYM DIABETOM TIPA 2 |
|
| Vol 16, No 17 (2009) |
Articles |
DIABETIChESKAYa PERIFERIChESKAYa POLINEVROPATIYa: SOVREMENNYE PREDSTAVLENIYa O PATOGENEZE I PODKhODY K TERAPII |
|
| Vol 16, No 17 (2009) |
Articles |
INNOVATsIONNYY KOMBINIROVANNYY PREPARAT GALVUS MET (VILDAGLIPTIN + METFORMIN) V LEChENII SAKhARNOGO DIABETA TIPA 2 |
|
| Vol 16, No 17 (2009) |
Articles |
GLIKEMIChESKIY KONTROL' U PATsIENTOV S SAKhARNYM DIABETOM TIPA 2 VO VREMYa INITsIATsII INSULINOTERAPII V REAL'NOY KLINIChESKOY PRAKTIKE ROSSIYSKOY FEDERATsII: REZUL'ATY ISSLEDOVANIYa CREDIT |
|
| Vol 17, No 3 (2010) |
Articles |
Use of long-acting insulin analogues in type 2 diabetes mellitus treatment (according to the data of international and Russian registries) |
|
| Vol 17, No 3 (2010) |
Articles |
New possibilities for diabetic peripheral neuropathy treatment |
|
| Vol 17, No 16 (2010) |
Articles |
POTENTIALS FOR USE OF DIPEPTIDYL PEPTIDASE-4 INHIBITORS IN TYPE 2 DIABETES MELLITUS: INITIATION AND CONTINUATION OF THERAPY |
|
| Vol 17, No 16 (2010) |
Articles |
CONTINUOUS SUBCUTANEOUS INSULIN INFUSION: EFFECTIVE METHOD FOR CONTROL OF TYPE 1 DIABETES MELLITUS |
|
| Vol 17, No 16 (2010) |
Articles |
ROLE OF SPECIALIZED NUTRITION IN PATIENTS WITH TYPE 2 DIABETES MELLITUS: CLINICAL EXPERIENCE OF USING OF GLUCERNA SR |
|
| Vol 18, No 3 (2011) |
Articles |
TYPE 2 DIABETES MELLITUS: POTENTIALS FOR ACHIEVEMENT OF OPTIMAL CONTROL WITHOUT SIDE EFFECTS |
|
| Vol 18, No 3 (2011) |
Articles |
INITIATION OF THERAPY WITH INSULIN PUMP IN PATIENTS WITH TYPE 1 DIABETES |
|
| Vol 18, No 3 (2011) |
Articles |
CLINICAL ASPECTS FOR USE OF DIPEPTIDYL PEPTIDASE-4 INHIBITORS IN COMBINATION WITH METFORMIN: BENEFITS FOR DIFFERENT GROUPS OF PATIENTS |
|
| Vol 18, No 3 (2011) |
Articles |
CENTRAL DIABETES INSIPIDUS: MODERN CONCEPTS AND THERAPEUTIC APPROACHES |
|
| Vol 19, No 3 (2012) |
Articles |
GLUCAGON-LIKE PEPTIDE-1: FROM PHYSIOLOGY TO EFFECTIVE MANAGEMENT OF TYPE 2 DIABETES MELLITUS |
|
| Vol 19, No 3 (2012) |
Articles |
TYPE 2 DIABETES MELLITUS AND CONCOMITANT DISEASES: ADVANTAGES OF USE OF DIPEPTIDYL PEPTIDASE-4 INHIBITOR SAXAGLIPTIN (ONGLYZA ®) |
|
| Vol 19, No 3 (2012) |
Articles |
APPLICATION OF VILDAGLIPTIN IN COMBINATION WITH INSULIN IN TYPE 2 DIABETES MELLITUS |
|
| Vol 19, No 3 (2012) |
Articles |
HOW TO EFFECTIVELY MANAGE TWO MAJOR DEFECTS IN TYPE 2 DIABETES MELLITUS? |
|
| Vol 19, No 7 (2012) |
Articles |
DIPEPTIDYL PEPTIDASE-4 INHIBITORS IN COMBINATION WITH METFORMIN: EXPERIENCE OF USE OF GALVUS MET IN REAL-LIFE CLINICAL PRACTICE IN MOSCOW |
|
| Vol 19, No 7 (2012) |
Articles |
DPP-4 INHIBITORS: TODAY AND TOMORROW. WHAT WE EXPECT FROM INCRETIN-STIMULATING THERAPY? |
|
